Jingying Cheng

Statistics

Publications

Citations

107

H-Index

Active since

2016

Affiliations

Institute of Hematology & Blood Diseases Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Jingying Cheng is an author at Institute of Hematology & Blood Diseases Hospital specializing in molecular oncology, oncology, and acute myeloid leukemia progression.

Publications per year

2016–2020

Publications

CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway

Jingying Cheng, Ying Li, Shiqi Liu et al. · The FASEB Journal · 2018 · 46 citations

Life Sciences, Cell Biology, Oncology +15

CXCL8 is associated with the recurrence of patients with acute myeloid leukemia and cell proliferation in leukemia cell lines

Yuanye Li, Jingying Cheng, Ying Li et al. · Biochemical and Biophysical Research Communications · 2018 · 19 citations

Medicine, Cancer Biology, Oncology +12

Sam68 affects cell proliferation and apoptosis of human adult T-acute lymphoblastic leukemia cells via AKT/mTOR signal pathway

Qi Wang, Yuanye Li, Jingying Cheng et al. · Leukemia Research · 2016 · 16 citations

Life Sciences, Molecular Biology, Oncology +13

ATG5 regulates mesenchymal stem cells differentiation and mediates chemosensitivity in acute myeloid leukemia

Ying Li, Yajing Jiang, Jingying Cheng et al. · Biochemical and Biophysical Research Communications · 2020 · 14 citations

Medicine, Cell Biology, Oncology +14

Upregulation of<i>AKR1C1</i>in mesenchymal stromal cells promotes the survival of acute myeloid leukaemia cells

Yajing Jiang, Ying Li, Jingying Cheng et al. · British Journal of Haematology · 2020 · 12 citations · Full text

Life Sciences, Hematology, Molecular Biology +17

1–5 of 5